Cardiac hypertrophy is negatively regulated by miR-541

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Heart failure is a significant cause of mortality, particularly in aging individuals.
• Cardiac hypertrophy, an adaptive response to stress, can progress to heart failure.
• MicroRNAs (miRNAs) play crucial roles in cardiovascular regulation.

Purpose of the Study:

• To investigate the role of miR-541 in cardiac hypertrophy.
• To elucidate the relationship between miR-541 and microphthalmia-associated transcription factor (MITF) in cardiac hypertrophy.
• To identify novel therapeutic targets for cardiac hypertrophy.

Main Methods:

• Utilized angiotensin II (Ang-II) to induce cardiac hypertrophy in cultured cardiomyocytes and mouse models.
• Generated miR-541 transgenic mice and MITF mutant mice (MITF(ce/ce)).
• Performed gene knockdown experiments for MITF and miR-541.

Main Results:

• miR-541 levels were decreased in Ang-II treated cardiomyocytes.
• Overexpression of miR-541 reduced Ang-II-induced hypertrophic phenotype in vitro and in vivo.
• MITF negatively regulates miR-541 expression transcriptionally.
• MITF knockdown reduced cardiac hypertrophy, an effect dependent on miR-541.

Conclusions:

• A novel regulatory pathway involving miR-541 and MITF in cardiac hypertrophy was identified.
• miR-541 acts as a tumor suppressor in cardiac hypertrophy.
• Modulating miR-541 and MITF levels offers a potential therapeutic strategy for cardiac hypertrophy.